Publications
2021
The clinical and microbiological utility of inhaled aztreonam lysine for the treatment of acute pulmonary exacerbations of cystic fibrosis: An open-label randomised crossover study (AZTEC-CF)
Frost, F., Young, G. R., Wright, L., Miah, N., Smith, D. L., Winstanley, C., . . . Nazareth, D. (2021). The clinical and microbiological utility of inhaled aztreonam lysine for the treatment of acute pulmonary exacerbations of cystic fibrosis: An open-label randomised crossover study (AZTEC-CF). JOURNAL OF CYSTIC FIBROSIS, 20(6), 994-1002. doi:10.1016/j.jcf.2020.12.012
2020
P079 Optimisation of an approach for characterisation of the cystic fibrosis lung microbiome using whole-genome metagenomics
Wright, L. L., Nicholls, S., Quick, J., Frost, F., Nazareth, D., Loman, N., . . . Fothergill, J. L. (2020). P079 Optimisation of an approach for characterisation of the cystic fibrosis lung microbiome using whole-genome metagenomics. Journal of Cystic Fibrosis, 19, S77. doi:10.1016/s1569-1993(20)30414-8
P151 Monitoring clinical and microbiological changes in people with cystic fibrosis during the early stages of modulator therapy in an adult centre in the UK
FitzMaurice, T. S., Wright, L., Frost, F., Scott, E., Winstanley, C., Walshaw, M., . . . Fothergill, J. L. (2020). P151 Monitoring clinical and microbiological changes in people with cystic fibrosis during the early stages of modulator therapy in an adult centre in the UK. Journal of Cystic Fibrosis, 19, S98. doi:10.1016/s1569-1993(20)30486-0
WS08.6 Pseudomonas aeruginosa phage gene expression changes in co-culture with Streptococcus and Rothia spp. in an artificial sputum model
Wright, L. L., Cazares, A., Figueroa, W., Walshaw, M., O’Brien, S., Winstanley, C., & Fothergill, J. L. (2020). WS08.6 Pseudomonas aeruginosa phage gene expression changes in co-culture with Streptococcus and Rothia spp. in an artificial sputum model. Journal of Cystic Fibrosis, 19, S14-S15. doi:10.1016/s1569-1993(20)30211-3
A megaplasmid family driving dissemination of multidrug resistance in Pseudomonas.
Cazares, A., Moore, M. P., Hall, J. P. J., Wright, L. L., Grimes, M., Emond-Rhéault, J. -G., . . . Winstanley, C. (2020). A megaplasmid family driving dissemination of multidrug resistance in Pseudomonas.. Nature communications, 11(1). doi:10.1038/s41467-020-15081-7
2019
Reservoirs of resistance: polymyxin resistance in veterinary-associated companion animal isolates of <i>Pseudomonas aeruginosa</i>
Scott, A., Pottenger, S., Timofte, D., Moore, M., Wright, L., Kukavica-Ibrulj, I., . . . Fothergill, J. L. (2019). Reservoirs of resistance: polymyxin resistance in veterinary-associated companion animal isolates of <i>Pseudomonas aeruginosa</i>. VETERINARY RECORD, 185(7). doi:10.1136/vr.105075
P131 Pseudomonas aeruginosa gene expression changes when co-cultured with common cystic fibrosis lung microbiota in an artificial sputum model
Wright, L. L., Cazares, A., Figueroa, W., Chatterley, L., O'Brien, S., Winstanley, C., & Fothergill, J. L. (2019). P131 Pseudomonas aeruginosa gene expression changes when co-cultured with common cystic fibrosis lung microbiota in an artificial sputum model. Journal of Cystic Fibrosis, 18, S94. doi:10.1016/s1569-1993(19)30425-4